Amarin reported $228M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Aerie Pharmaceuticals AERI:US $ 39.44M 17M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Amarin AMRN:US $ 228M 8.85M
AstraZeneca AZN:LN 4817M 945M
Biocryst Pharmaceuticals BCRX:US $ 417.48M 21.98M
Epizyme EPZM:US $ 77.42M 20.92M
Esperion Therapeutics ESPR:US $ 122.94M 27.42M
GlaxoSmithKline GSK:LN 6465M 4502M
Halozyme Therapeutics HALO:US $ 117.84M 0.88M
Heron Therapeutics HRTX:US $ 56.91M 33.63M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
IONIS PHARMACEUT IONS:US $ 542.51M 326.68M
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Novartis NOVN:VX SF 3625M 10227M
Teva Pharmaceutical Industries TEVA:US $ 2058M 117M